Human papillomavirus (HPV) infection rates are increasing among women under age 40 who haven't received the HPV vaccination; Ride Aid will stop the sale of e-cigarettes over the next 90 days; the Ohio governor signed a ban on abortion after a detectable heartbeat with no exceptions for pregancies resulting from rape or incest.
Rates of human papillomavirus (HPV) are increasing among women under age 40 who did not receive the HPV vaccine, putting them at higher risk for HPV-related cancers, such as cervical cancer. A study from The University of Michigan developed a model that used data on both HPV infection and past infection and found that while there may be a significant increase in HPV among younger adults, HPV vaccination can likely mitigate adverse HPV-related outcomes, including genital warts and cancer. However, the study did not identify why there was a spike in HPV infection among the age group.Rite Aid has announced that it will stop the sale of e-cigarettes and vaping products over the next 90 days, citing a 38% increase in e-cigarette use among high schoolers in 2018 and other evidence that e-cigarette use has increased among children and teens. According to The Wall Street Journal, the company will continue to sell traditional cigarettes. Competitor CVS no longer sells e-cigarettes or cigarettes and Walgreens continues to sell both, although the chain has indicated that it is testing tobacco-free stores throughout the country after facing pressure from federal regulators and some investors.Governor Mike DeWine, R-Ohio, has signed into law the strictest abortion restrictions in the country, banning abortion after a detectable heartbeat, reported the Associated Press. The law makes no exceptions for pregnancies resulting from rape or incest. Doctors have said this can be as early as 5 weeks into pregnancy, before many women know they are pregnant. The bill had previously been vetoed twice by DeWine’s predecessor John Kasich, R-Ohio. Before the bill was signed, the American Civil Liberties Union of Ohio indicated that it would challenge the law on behalf of 4 Ohio abortion clinics.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More